Qutoutiao Inc. Reports Third Quarter 2018 Unaudited Financial Results
SHANGHAI, China, Nov. 12, 2018 (GLOBE NEWSWIRE) — Qutoutiao Inc. (“Qutoutiao”, the “Company” or “We”) (NASDAQ: QTT), an innovative and […]
Micron Collaborates with Premium German Automaker to Advance Automotive Memory Technologies
Testing and Development of Automotive Memory Solutions to be Conducted at Micron’s State-of-the-Art Lab BOISE, Idaho and MUNICH, Germany, Nov. […]
Redfund Begins Globalizing Tea Beverage Brand Mary’s Wellness
Portfolio Clients Move to List On Public Markets VANCOUVER, British Columbia, Nov. 12, 2018 (GLOBE NEWSWIRE) — Redfund Capital Corp […]
Mimecast Wins Global Business Continuity Institute Award for Continuity and Resilience
Mimecast Mailbox Continuity Highlighted as a Strategic Asset for Cyber Resilience for Email LONDON, Nov. 12, 2018 (GLOBE NEWSWIRE) — […]
Appointment of Joint Broker
Summit Therapeutics plc (‘Summit’ or the ’Company’) Appointment of Joint Broker Oxford, UK, and Cambridge, MA, US, 12 November 2018 […]
Publication of Scheme Document
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION […]
Cartier Continues to Widen Zones 5 below Chimo Mine with 14.6 g/t Au over 3.0 m within 5.8 g/t Au over 10.0 m
VAL-D’OR, Quebec, Nov. 12, 2018 (GLOBE NEWSWIRE) — Cartier Resources Inc. (TSX-V: ECR) (“Cartier”) reports additional drill hole intersections grading […]
AGC Networks to Acquire Black Box, Creating a Significant Global Technology Solutions Provider
Expands Offerings, Scale and Geographic Reach to Service Global Enterprise Clients Offer Price Represents a 24% Premium Over Most Recent […]
Clinically Meaningful Outcome in NIH Trial of MPC-150-IM for Heart Failure LVAD Recipients Provides Pathway for Potential Regulatory Approval
NEW YORK and MELBOURNE, Australia, Nov. 11, 2018 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB) today announced that results from […]
Fate Therapeutics Announces Encouraging Dose-Escalation Clinical Data of FATE-NK100 and Provides Regulatory Update on Landmark IND Application for FT500
NK100 Shows Clinical Benefit in Treating Advanced Hematologic Malignancies and Solid Tumors Disease Control Shown in All Subjects Re-treated with […]
